|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
1 Prince Henry's Institute of Medical Research, Clayton, 3168 Victoria, Australia2 Department of Physiology, Monash University, Clayton, 3800 Victoria, Australia
(Correspondence should be addressed to A J Rickard; Email: amanda.rickard{at}princehenrys.org)
The mineralocorticoid receptor (MR) and glucocorticoid receptor are ligand-activated transcription factors that have important physiological and pathophysiological actions in a broad range of cell types including monocytes and macrophages. While the glucocorticoids cortisol and corticosterone have well-described anti-inflammatory actions on both recruited and tissue resident macrophages, a role for the mineralocorticoid aldosterone in these cells is largely undefined. Emerging evidence, however, suggests that MR signalling may promote pro-inflammatory effects. This review will discuss the current understanding of the role of corticosteroid receptors in macrophages and their effect on diseases involving inflammation, with a particular focus on cardiovascular disease.
This article has been cited by other articles:
![]() |
A. Bergmann, C. Eulenberg, M. Wellner, S. Rolle, F. Luft, and R. Kettritz Aldosterone Abrogates Nuclear Factor {kappa}B-Mediated Tumor Necrosis Factor {alpha} Production in Human Neutrophils via the Mineralocorticoid Receptor Hypertension, February 1, 2010; 55(2): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Guagliardo, K. N. West, L. P. McCluskey, and D. L. Hill Attenuation of peripheral salt taste responses and local immune function contralateral to gustatory nerve injury: effects of aldosterone Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1103 - R1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Carlson, W. Cui, Q. Zhang, X. Xu, F. Mercan, A. M. Bennett, and A. Vignery Role of MKP-1 in Osteoclasts and Bone Homeostasis Am. J. Pathol., October 1, 2009; 175(4): 1564 - 1573. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |